14 October 2014
Dechra® Pharmaceuticals PLC
(Dechra or the Company)
Director / PDMR Shareholding
Grant of SAYE options:
Dechra Pharmaceuticals PLC announces that yesterday the following Directors and PDMRs were granted options over ordinary shares of 1p each in the Company pursuant to the Dechra Pharmaceuticals Save As You Earn Scheme (the Options).
The Options have been granted with an exercise price of £6.14.
Name |
Capacity |
Options Granted |
Ian Page |
Director |
1,465 |
Anne-Francoise Nesmes |
Director |
1,465 |
Zoe Goulding |
PDMR |
2,052 |
For further information, please contact:
Zoe Goulding, Company Secretary
Telephone number: 01606 814730
About Dechra
Dechra is an international specialist veterinary pharmaceuticals and related products business. Our expertise is in the development, manufacturing and sales and marketing of high quality products exclusively for veterinarians worldwide. Dechra's business is unique as the majority of its products are used to treat medical conditions for which there is no other effective solution or have a clinical or dosing advantage over competitor products. For more information please visit: www.dechra.com
Trademarks
Dechra and the Dechra "D" logo are registered trademarks of Dechra Pharmaceuticals PLC.